SCHEMBL30737013

SCHEMBL30737013

C#CCOCCOCCOCCOCCOCCOCCOc1cccc(CN[C@@H](CCC(C)(C)C)C(=O)OC)c1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CD274 Q9NZQ7 2/20 0.36
MAPK1 P28482 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
MAOB P27338 1/20 0.35
POLB P06746 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP13 P45452 1/20 0.35
ALDH1A1 P00352 1/20 0.34
SIRT2 Q8IXJ6 1/20 0.34
FFAR1 O14842 1/20 0.34
PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30737368 0.79 SORT1 (0.42) TSHRKDM4EMEN1KMT2AALDH1A1
SCHEMBL26992821 0.77 MAOB (0.43) KDM4EMAOBMMP13ALDH1A1
SCHEMBL30737295 0.73 ALDH1A1 (0.46) MEN1KMT2AALDH1A1
SCHEMBL29213363 0.72 MEN1 (0.51) MEN1KMT2APOLBMMP13ALDH1A1
SCHEMBL29213358 0.72 MEN1 (0.51) MEN1KMT2APOLBMMP13ALDH1A1
SCHEMBL30903297 0.72 MEN1 (0.51) MEN1KMT2APOLBMMP13ALDH1A1
SCHEMBL27165689 0.69 FFAR1 (0.51) TDP1KDM4EALDH1A1FFAR1
SCHEMBL27165490 0.69 FFAR1 (0.51) TDP1KDM4EALDH1A1FFAR1
SCHEMBL31725729 0.69 KLK5 (0.52) MEN1KMT2APOLBALDH1A1
SCHEMBL26992822 0.68 MAOB (0.40) MAPK1TSHRTDP1KDM4EMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250345446-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2025-11-13 US disclosed
EP-4543858-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES Draupnir Bio ApS (DK) 2025-04-30 EP disclosed
WO-2023247754-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2023-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250345446-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES SORT1, SCARB1, LAMP1 CD274 1962/4885MAPK1 3611/4885L3MBTL1 1760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.